Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antipsychotic Discounts To Medicare Cards Are 15%-30% Off AWP; Abilify Is Outlier

This article was originally published in The Pink Sheet Daily

Executive Summary

Bristol-Myers Squibb's antipsychotic Abilify (aripiprazole) is being offered at less than half of list price under the National Community Pharmacists Association's Medicare-endorsed discount card brands

You may also be interested in...



"Pfizer Pfriends" Discount Program Offers Medicare Card Model To Uninsured

The company will provide discounts through a two-tiered structure to people who lack drug coverage, regardless of age or income level. The discounts range from 15% to 37% off of retail prices for Pfizer products. Pfizer will publicize the discounted prices via a website and call center that will launch in August.

"Pfizer Pfriends" Discount Program Offers Medicare Card Model To Uninsured

The company will provide discounts through a two-tiered structure to people who lack drug coverage, regardless of age or income level. The discounts range from 15% to 37% off of retail prices for Pfizer products. Pfizer will publicize the discounted prices via a website and call center that will launch in August.

NCPA Plans Medicare Rx Card Partnership

The independent pharmacy group will work with a pharmacy benefits manager and a software products firm to offer a Medicare-endorsed drug discount card.

Topics

UsernamePublicRestriction

Register

PS059357

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel